In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent

Blastic plasmacytoid dendritic cell neoplasm is an aggressive malignancy derived from plasmacytoid dendritic cells. There is currently no accepted standard of care for treating this neoplasm, and therapeutic strategies have never been prospectively evaluated. Since blastic plasmacytoid dendritic cel...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Haematologica
Autors principals: Angelot-Delettre, Fanny, Roggy, Anne, Frankel, Arthur E., Lamarthee, Baptiste, Seilles, Estelle, Biichle, Sabeha, Royer, Bernard, Deconinck, Eric, Rowinsky, Eric K., Brooks, Christopher, Bardet, Valerie, Benet, Blandine, Bennani, Hind, Benseddik, Zehaira, Debliquis, Agathe, Lusina, Daniel, Roussel, Mikael, Solly, Françoise, Ticchioni, Michel, Saas, Philippe, Garnache-Ottou, Francine
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2015
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4803130/
https://ncbi.nlm.nih.gov/pubmed/25381130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.111740
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars